Acarbose promotes remission of both early and late dumping syndromes in post-bariatric patients
Flavio A Cadegiani,1 Osvalmir Sá Silva2 1Division of Endocrinology and Metabolism, Department of Medicine, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, 2Corpometria Institute, an Obesity and Endocrinology Center, Brasilia, DF, Brazil...
Guardado en:
Autores principales: | , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5e483b0d35a044b0860d7968be7d559f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:5e483b0d35a044b0860d7968be7d559f |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:5e483b0d35a044b0860d7968be7d559f2021-12-02T01:07:19ZAcarbose promotes remission of both early and late dumping syndromes in post-bariatric patients1178-7007https://doaj.org/article/5e483b0d35a044b0860d7968be7d559f2016-12-01T00:00:00Zhttps://www.dovepress.com/acarbose-promotes-remission-of-both-early-and-late-dumping-syndromes-i-peer-reviewed-article-DMSOhttps://doaj.org/toc/1178-7007Flavio A Cadegiani,1 Osvalmir Sá Silva2 1Division of Endocrinology and Metabolism, Department of Medicine, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, 2Corpometria Institute, an Obesity and Endocrinology Center, Brasilia, DF, Brazil Objective: Acarbose is a glucosidase inhibitor that slows carbohydrate digestion. It could thus be effective to promote remission of dumping syndrome (DS). Previous studies associating acarbose and late dumping, although not early dumping, have been reported. Herein, we aimed to evaluate the role of acarbose in dumping syndrome prevention and treatment and in resistive exercises resistance in bariatric subjects. Methods: Bariatric patients with DS and complete adherence to diet plan and resistive exercises were included (n=25). Number of early and late episodes, self-referred intensity of each episode, and ability to increase intensity of resistive exercise were evaluated, on a 0–10 scale. Acarbose was administered orally (50 mg) for 6 months, 4–5 times a day before meals. Results: Acarbose administration was associated with a decrease in the number of early (2.18–0.31) and late (2.79–0.12) episodes per week and intensity of each episode (6.10–1.65) and an increase in the ability to perform resistive exercises (3.03–7.12). Complete remission of DS was seen in 21 patients (84%), which persisted for 6 months with the use of acarbose. Conclusion: Acarbose prevented dumping in almost all studied subjects and helped improve exercise capacity. Keywords: dumping syndrome, bariatric surgery, post-bariatric, obesityCadegiani FASilva OSDove Medical PressarticleDumping SyndromeBariatric SurgeryPost-bariatricObesitySpecialties of internal medicineRC581-951ENDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol Volume 9, Pp 443-446 (2016) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Dumping Syndrome Bariatric Surgery Post-bariatric Obesity Specialties of internal medicine RC581-951 |
spellingShingle |
Dumping Syndrome Bariatric Surgery Post-bariatric Obesity Specialties of internal medicine RC581-951 Cadegiani FA Silva OS Acarbose promotes remission of both early and late dumping syndromes in post-bariatric patients |
description |
Flavio A Cadegiani,1 Osvalmir Sá Silva2 1Division of Endocrinology and Metabolism, Department of Medicine, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, 2Corpometria Institute, an Obesity and Endocrinology Center, Brasilia, DF, Brazil Objective: Acarbose is a glucosidase inhibitor that slows carbohydrate digestion. It could thus be effective to promote remission of dumping syndrome (DS). Previous studies associating acarbose and late dumping, although not early dumping, have been reported. Herein, we aimed to evaluate the role of acarbose in dumping syndrome prevention and treatment and in resistive exercises resistance in bariatric subjects. Methods: Bariatric patients with DS and complete adherence to diet plan and resistive exercises were included (n=25). Number of early and late episodes, self-referred intensity of each episode, and ability to increase intensity of resistive exercise were evaluated, on a 0–10 scale. Acarbose was administered orally (50 mg) for 6 months, 4–5 times a day before meals. Results: Acarbose administration was associated with a decrease in the number of early (2.18–0.31) and late (2.79–0.12) episodes per week and intensity of each episode (6.10–1.65) and an increase in the ability to perform resistive exercises (3.03–7.12). Complete remission of DS was seen in 21 patients (84%), which persisted for 6 months with the use of acarbose. Conclusion: Acarbose prevented dumping in almost all studied subjects and helped improve exercise capacity. Keywords: dumping syndrome, bariatric surgery, post-bariatric, obesity |
format |
article |
author |
Cadegiani FA Silva OS |
author_facet |
Cadegiani FA Silva OS |
author_sort |
Cadegiani FA |
title |
Acarbose promotes remission of both early and late dumping syndromes in post-bariatric patients |
title_short |
Acarbose promotes remission of both early and late dumping syndromes in post-bariatric patients |
title_full |
Acarbose promotes remission of both early and late dumping syndromes in post-bariatric patients |
title_fullStr |
Acarbose promotes remission of both early and late dumping syndromes in post-bariatric patients |
title_full_unstemmed |
Acarbose promotes remission of both early and late dumping syndromes in post-bariatric patients |
title_sort |
acarbose promotes remission of both early and late dumping syndromes in post-bariatric patients |
publisher |
Dove Medical Press |
publishDate |
2016 |
url |
https://doaj.org/article/5e483b0d35a044b0860d7968be7d559f |
work_keys_str_mv |
AT cadegianifa acarbosepromotesremissionofbothearlyandlatedumpingsyndromesinpostbariatricpatients AT silvaos acarbosepromotesremissionofbothearlyandlatedumpingsyndromesinpostbariatricpatients |
_version_ |
1718403319215423488 |